Trials / Completed
CompletedNCT02557594
Clinical Trial to Assess the Safety and Pharmacokinetics of DA-2802 319mg and Viread 300mg in Healthy Male Volunteers
A Randomized, Open-label, Two-way Crossover Study to Assess the Safety and Pharmacokinetics of DA-2802 319mg and Viread 300mg After a Single Oral Dose in Healthy Male Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- Dong-A ST Co., Ltd. · Industry
- Sex
- Male
- Age
- 20 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
This Phase I clinical study is to evaluate the safety and pharmacokinetics of DA-2802 319mg and Viread 300mg after a single oral dose in healthy male volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Viread 300mg | single dose administration after 10hr fasting |
| DRUG | DA-2802 319mg | single dose administration after 10hr fasting |
Timeline
- Start date
- 2015-10-06
- Primary completion
- 2015-11-17
- Completion
- 2016-03-08
- First posted
- 2015-09-23
- Last updated
- 2017-04-12
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02557594. Inclusion in this directory is not an endorsement.